Clinical Pharmacokinetics

The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease

Catherine M. T. Sherwin, Tsuyoshi Fukuda, Hermine I. Brunner, Jens Goebel, Alexander A. Vinks

Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs

Thomas N. Kakuda, Monika Schöller-Gyüre, Richard M. W. Hoetelmans

Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia

Lie Michael George Limenta, Totsapol Jirasomprasert, Piyada Jittangprasert, Prapin Wilairat, Praveena Yamanont, Udom Chantharaksri, Suthat Fucharoen, Noppawan Phumala Morales

Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children

Elke H. J. Krekels, Joost DeJongh, Richard A. van Lingen, Caroline D. van der Marel, Imti Choonara, Anne M. Lynn, Meindert Danhof, Dick Tibboel, Catherijne Knibbe

Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

Mark Fineman, Shawn Flanagan, Kristin Taylor, Maria Aisporna, Larry Z. Shen, Kenneth F. Mace, Brandon Walsh, Michaela Diamant, Brenda Cirincione, Prajakti Kothare, Wen-I Li, Leigh MacConell

Erratum to: Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions

Erratum to: Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions

AJ Scheen